U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
Lihua Huang,Zhanpeng Lu,Xiaoqing Zhou,Liuliu He,Xiaoyan You,Chunmei Chen,Chunsheng Zou
DOI: https://doi.org/10.2147/COPD.S386269
2023-03-16
International Journal of COPD
Abstract:Lihua Huang, 1, &ast Zhanpeng Lu, 2, &ast Xiaoqing Zhou, 3 Liuliu He, 1 Xiaoyan You, 1 Chunmei Chen, 1 Chunsheng Zou 1 1 Department of Clinical Laboratory, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, People's Republic of China; 2 Department of Critical Care,The Eighth Affiliated Hospital of Sun Yat sen University, Shenzhen, People's Republic of China; 3 General Surgery Department, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lihua Huang, Department of Clinical Laboratory, The Second Affiliated Hospital of Gannan Medical University, 331 Yingbin Dadao, Xinfeng County, Ganzhou, Jiangxi Province, People's Republic of China, Tel +86 18970771329, Email Purpose: In the anaerobic metabolic pathway, lactate dehydrogenase (LDH) plays an important role in hypoxia, inflammation, and cell damage, making it a potential biomarker for the progression of chronic obstructive pulmonary disease (COPD). We aimed to examine the relationship between LDH levels and all-cause mortality in participants with COPD. Patients and Methods: Data of participants in the US National Health and Nutrition Examination Surveys (NHANES) 2007– 2012 aged ≥ 20 years who underwent spirometry tests were examined, and follow-up mortality data were obtained. According to serum LDH levels, participants with COPD were divided into five groups (59– 111, 112– 123, 124– 135, 136– 150, and 151– 344 U/L). To evaluate whether LDH levels were independently associated with COPD mortality, we used multivariate Cox regression analysis and smooth curve fitting. Results: We included 1320 subjects, 64 with stage III or IV COPD and 541 with stage II COPD. Over a median follow-up of 9.7 years (IQR: 7.8, 11.2), 252 of the 1320 subjects died. The mean LDH level was 132.5 U/L (standard deviation [SD], 27.0). A U-shaped relationship was observed between LDH levels and all-cause mortality. Below and above the inflection point, which was approximately 110 U/L, we found different slopes for the correlation between LDH and all-cause mortality of patients with COPD. Below the threshold, per 1-standard deviation (1SD) increase in LDH resulted in a 68% reduced risk of all-cause mortality (hazard ratio [HR] 0.32, 95% confidence interval [CI] 0.13– 0.81, P=0.016); conversely, above the threshold, per 1SD increase in LDH accelerated the risk of all-cause mortality (HR 1.23, 95% CI: 1.08– 1.41, P= 0.002). Conclusion: Using the nationally representative NHANES data, we found a U-shaped association between LDH level and all-cause mortality in participants with COPD. An optimal LDH level of approximately 110 U/L was associated with the lowest risk of all-cause mortality. Keywords: lactate dehydrogenase, pulmonary disease, chronic obstructive, nutrition surveys, nonlinear, threshold Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and progressive airflow obstruction. 1 In 2018, COPD was the fourth most common cause of death in the United States. 2 COPD was diagnosed in nearly 15.7 million Americans (6.4%). 3 In more than half of COPD cases, adults were unaware of their condition. 4 Age-adjusted mortality rates for COPD in the United States decreased among men between 1999 and 2014 but remained stable among women during the same period. 5 The prediction of mortality is important since it allows the identification of patients whose outcomes can be improved by implementing specific therapeutic measures. As a marker of tissue injury, necrosis, and hypoxia, lactate dehydrogenase (LDH) has an essential value in the diagnosis, treatment, and prognosis of cancer. 6 Furthermore, patients with COPD have increased LDH levels. These levels indicate underlying lung damage and inflammation and show the usefulness of LDH and its isoenzymes as indicators of lung damage or inflammation. 7 However, the relationship between LDH and all-cause mortality in patients with COPD has scarcely been studied. The primary aim of this study was to assess the association between LDH levels and all-cause mortality. The National Health and Nutrition Examination Survey (NHANES) is a major program of the National Center for Health Statistics (NCHS), an agency of the Centers for Disease Control and Prevention (CDC). This national survey is being conducted to assess the health of the entire United States (US) population. To generate population-level estimates, data is collected annually on a two-yea -Abstract Truncated-
respiratory system